Analysis of the Logistics System in the Management of Essential and Generic Drugs in Brazzaville


  • Jean Bruno Mokoko Faculty of Sciences and Health, University Marien Ngouabi Hospital and University Center of Brazzaville, Congo
  • Stéphane Meo Ikama Faculty of Sciences and Health, University Marien Ngouabi Hospital and University Center of Brazzaville, Congo
  • Wilson Fabrice Ondongo Faculty of Science and Health, Congo
  • Fabrice Ondongo Faculty of Sciences and Health, University Marien Ngouabi Hospital and University Center of Brazzaville, Congo


logistics system, management, generic essential drugs, Congo.


The logistics system in the management of essential and generic medicines (MEGs) is the fundamental point to provide quality health care to the population, in order to ensure the sustainability of integrated health center (ISC) activities. The purpose of this work was to assess the performance of the ITC logistics system of Brazzaville by analyzing the different indicators. This study was a retrospective and observational study. The strategy consisted of conducting a survey among a sample of 17 CSIs in the seven districts of the city of Brazzaville. Data were collected over a three-month period following a one-on-one interview with Drug Management Officers, Document Operations, and Drug Availability Observation in CSI pharmacies. These data were recorded on a survey sheet, and an observation grid was established.

The analysis of logistic system variables revealed that: drug selection was fair in 76.5% of CSI and satisfactory in 23.5%. Quantification was good in 17.6% of cases, fair in 58.8%, and unsatisfactory in 23.5%. Storage conditions were fair in 41.2% and unsatisfactory in 29.4%. Distribution is unsatisfactory in the majority of CSIs. 76.46% of CSIs have unsatisfactory management tools. Drug use is fair at 47% with low availability of drugs.

The study found that  the improvement of MEG availability is related to the organization of the management circuit and the logistics system.


[1]. CEMAC. Common Pharmaceutical Policy. 2007,20p.
[2]. Declaration of Alma-Ata. International conference on Primary Health. Alma-Ata, USSSR. 1978,3p.
[3]. Monekosso G. L. Bamako Initiative. Some general principles. WHO / DRAO. Brazzaville 1989,10p.
[4]. Riddle V., Nitiema A. P., Dadjoari M. Improve accessibility of essential drug for the population of medical region in Burkina Faso. Santé2005; 15 (3): 172-82.
[5]. Ministry of Health Congo. Round table on the problem of drugs in Congo. Final report. 2008, 57p.
[6]. Convention Government of the Republic of Congo-COMEG, 10/07/2006 COMEG, Association Declaration Receipt N ° 352/05 / MATD / DGAT / DER / SAG.
[7]. Ministry of Health and Population, Pharmacy, Laboratory and Drug Branch. Evaluation of the Pharmaceutical Sector of Congo 2006, 76p.
[8]. WHO AFRO. WHO Strategy for Cooperation with the Union of Comoros 2005-2009. Moroni 2004, 33 p.
[9]. Nkhogho P, Gregoire JP, Moisan J, Gaudet M. The determinants of prescribing generic essential drugs in primary health care (Gabon) 2006. <> accessed 9th September November 2010.
[10]. WHO. Regional strategy for better access to medicines. 2004-2007. Western Pacific Regional Office 2003.40p.
[11]. Nkunzimana C. Availability of essential drugs under generic names in public and private non-profit health facilities in the Atlantic Department (Benin). Cotonou 1996; Memory No. 108 / IRSP. Alfred Comlan Regional Institute of Public Health QUENUM Ouidah-Benin, 1996, 66 p.
[12]. Ministry of Health. Evaluation of the IST Drug Management Logistics System Ministry of Health, Burkina Faso, Ouagadougou 2003,46 p.
[13]. Moore G. Partnership Evaluation of the Family Planning Logistics Management Project in Mali. Bamako 1994,52 p.
[14]. Boussengar L. Analysis of the management of medical devices at the level of an emergency reception facility. Case of Ibn Sina Hospital in Rabat (Morocco) 2004, 109p.
[15]. Ministry of Health Congo. National Procurement Plan 2006, 15p.
[16]. Ministry of Public Health of the Democratic Republic of Congo. Essential Medicines Management in the community health sites of the Kasai CRS assisted health area: 2008 supervision report, 28p.
[17]. Somda C. Evaluation of the generic essential drugs management logistics system in Kpomassé commune, Benin. Memory No. 413 / IRSP / 2006. Master in Public Health, Regional Institute of Public Health Alfred Comlan QUENUM Ouidah -BENIN, 2006, 86p.
[18]. Ministry of Health, Social Affairs and Family, Congo. Drug Management Manual for Pharmacies in CSI 2006, 20p.
[19]. Trap B, Todd C H, Moore H., Laing R. The impact of monitoring and control of a drug. Health Policy and Planning 2001; 16 (3): 273-80.
[20]. Cheraghali M, Nikfar S, Bahrami A, Rahimi V, Asadi A, Tirdad F et al. Evaluation of availability, accessibility and prescribing pattern of medicines in the Islamic Republic of Iran. Eastern Mediterranean Health Journal 2004; 10 (3): 406-15.
[21]. Niangaly A, Kante N, SoumareN'diaye A. Quality of care in health centers in the Kolikoro region (Mali). Med Afr Black 2001; 48 (7): 300-4.
[22]. Audibert M, Roodenbeke E. Use of first level health services in Mali: situation analysis and perspectives. World Bank, Africa Region, April 2005,68p.




How to Cite

Mokoko, J. B., Meo Ikama, S., Fabrice Ondongo, W., & Ondongo, F. (2018). Analysis of the Logistics System in the Management of Essential and Generic Drugs in Brazzaville. American Scientific Research Journal for Engineering, Technology, and Sciences, 47(1), 116–124. Retrieved from